Develops drugs for various diseases.
Dec 2025Revenue $296K/yrExpenses $7.45M/yr
No trendCash runway ≈ 1 months from Jun 2026
Figures by year
When will Abvc Biopharma be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $296K and expenses $7.45M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $296K | $7.45M | −$7.15M |
| Dec 2024 | $0.00 | $4.71M | −$4.71M |
| Dec 2023 | $152K | $6.92M | −$6.77M |
| Dec 2022 | $970K | $16.1M | −$15.1M |
| Dec 2021 | $356K | $12.1M | −$11.7M |
| Dec 2020 | $483K | $8.99M | −$8.51M |
| Dec 2019 | $702K | $4.16M | −$3.46M |
| Dec 2018 | $6.96K | $2.79M | −$2.78M |
| Sep 2013 | $7.79K | $185K | −$177K |
| Sep 2012 | $5.71K | $1.15M | −$1.14M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.